EBONY FUNCHES: Open Payments
NPI 1639569247 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,606 in 58 payments from 29 companies in 2025. Trend: 2023 $3,464 · 2024 $3,587 · 2025 $5,606
Food & beverage: $5,606
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $763 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $753 |
| Gilead Sciences, Inc. | 6 | $587 |
| Novo Nordisk Inc | 4 | $347 |
| Alexion Pharmaceuticals, Inc. | 2 | $253 |
| Otsuka America Pharmaceutical, Inc. | 4 | $196 |
| Inspire Medical Systems, Inc. | 1 | $168 |
| Corcept Therapeutics | 3 | $166 |
| Neurocrine BioSciences, Inc. | 1 | $150 |
| Hologic Sales and Service, LLC | 1 | $147 |
Products named: INVEGA SUSTENNA, CAPLYTA, Wegovy, Yeztugo, INSPIRE, Korlym, INGREZZA, APTIMA.
Industry payments across CA — which companies pay providers there.
